To address this, we developed an Fc variant that precisely modulates pH-dependent FcRn binding kinetics, accelerates FcRn association at acidic pH, and promotes rapid dissociation at neutral pH, thereby enhancing FcRn-driven intracellular transport, outcompeting endogenous IgG, and achieving unprecedented improvement in the serum half-life of therapeutic antibodies. == Results == Using comprehensive site-directed saturation mutagenesis coupled with functional screening, we generated a diverse panel of Fc variants and recognized two with distinct FcRn binding kinetics: YML (L309Y/Q311M/M428L), which exhibited superior FcRn association at acidic pH and accelerated dissociation at neutral pH, and EML (L309E/Q311M/M428L), which displayed attenuated binding kinetics. Norfluoxetine transport, outcompeting endogenous IgG, and achieving unprecedented improvement in the serum half-life of restorative antibodies. == Results == Using comprehensive site-directed saturation mutagenesis coupled with practical screening, we generated a diverse panel of Fc variants and recognized two with unique FcRn binding kinetics: YML (L309Y/Q311M/M428L), which exhibited superior FcRn association at acidic pH and accelerated dissociation Norfluoxetine at neutral pH, and EML (L309E/Q311M/M428L), which displayed attenuated binding kinetics. In human being FcRn transgenic mice, YML prolonged the serum half-life of clinically used trastuzumab having a wild-type Fc by 6.1-fold, demonstrating a remarkable improvement over previously reported Fc-engineered variants, including PFc29 (Q311R/M428L) and DHS (L309D/Q311H/N434S), which represent the most effective Fc modifications for prolonging serum persistence to day. This in vivo validation underscores the pivotal part of FcRn kinetic tuning in overcoming endogenous IgG competition and increasing FcRn-mediated antibody transport. Additionally, YML exhibited potent complement-dependent cytotoxicity (CDC) while keeping beneficial physicochemical properties. == Summary == This study presents a rational Fc engineering platform to optimize FcRn binding kinetics, dealing with a previously unconsidered challengeendogenous IgG competition during intracellular trafficking of restorative antibodies. The unique kinetic behaviors of YML and EML highlight the essential necessity of exact control over pH-dependent association and dissociation rates in FcRn binding. Rabbit Polyclonal to FRS3 YML represents a next-generation Fc platform, offering enhanced pharmacokinetics and improved effector functions, thus providing a powerful strategy for developing biologics with superior serum persistence and restorative effectiveness. == Supplementary Info == The online version consists of supplementary material available at 10.1186/s13036-025-00506-y. Keywords:Restorative antibody, FcRn, pH-dependent FcRn binding kinetics, Endogenous IgG competition, Serum half-life, Complement-dependent cytotoxicity == Intro == Restorative antibodies with prolonged serum half-lives provide significant advantages in treating a broad spectrum of diseases, including cancer, chronic inflammatory disorders, and infectious diseases, where sustained systemic drug availability is essential. By ensuring long term target engagement, these antibodies enhance restorative efficacy, reduce dosing frequency, and ultimately improve patient quality of life [1,2]. As a result, considerable research attempts in academia and market have been directed toward executive antibodies with optimized pharmacokinetic profiles to maximize their therapeutic energy. Among the various factors influencing IgG half-lifesuch as hydrophobicity [3], isoelectric point [4], and overall charge [3]and clearance through on-target or off-target relationships [5,6] influence antibody half-life, the primary determinant of IgG serum persistence is definitely its interaction with the neonatal Fc receptor (FcRn) [79]. FcRn, a heterodimer consisting Norfluoxetine of an MHC class I-like heavy chain and a 2-microglobulin (2m) subunit, governs the pH-dependent intracellular trafficking of IgG, a finely tuned process integral to antibody homeostasis and humoral immunity [2,10,11]. At acidic endosomal pH (5.56.5), FcRn binds IgG via protonated histidine residues (H310, H433, H435), facilitating receptor-mediated recycling and transcytosis. At physiological pH (7.4), deprotonation of these residues induces IgG launch, allowing efficient re-entry into blood circulation while avoiding lysosomal degradation [2,1113]. This dynamic FcRn-IgG interaction, characterized by iterative binding and dissociation cycles, dictates the long term serum persistence of IgG and represents a fundamental parameter in antibody executive strategies. Leveraging this mechanistic platform, researchers have developed Fc-engineered variants designed to lengthen serum half-life by enhancing pH-dependent FcRn equilibrium binding affinity [1421]. Notable variants, including M252Y/S254T/T256E (YTE) [15] and M428L/N434S (LS) [14], show improved FcRn binding at acidic pH, therefore improving receptor-mediated recycling and extending in vivo blood circulation. These modifications possess driven major developments in antibody-based therapeutics, with YTE integrated into FDA-approved Beyfortus(nirsevimab-alip) for RSV prophylaxis in babies [22] and Evusheld(tixagevimab/cilgavimab) for SARS-CoV-2 prophylaxis [23], while LS has been utilized in Ultomiris(ravulizumab-cwvz) for paroxysmal nocturnal hemoglobinuria (PNH) [24], as well as with sotrovimab for SARS-CoV-2 [25]. These good examples highlight the serious clinical effect of Fc executive in refining antibody pharmacokinetics and extending serum half-life. Despite these developments, a persistent challenge in Fc executive lies in achieving a finely balanced interplay between high-affinity FcRn binding at endosomal pH and efficient IgG dissociation at neutral pH. Many Fc variants that exhibit enhanced FcRn affinity at acidic pH also display excessive retention at physiological pH, impairing receptor dissociation and leading to intracellular build up and degradation [2628]. This Norfluoxetine limitation ultimately constrains half-life extension, underscoring the necessity of executive Fc variants with accelerated FcRn dissociation at.